2018
DOI: 10.1016/j.conctc.2018.03.009
|View full text |Cite
|
Sign up to set email alerts
|

Outpatient versus inpatient mixed meal tolerance and arginine stimulation testing yields comparable measures of variability for assessment of beta cell function

Abstract: Standard practice to minimize variability in beta cell function (BCF) measurement is to test in inpatient (IP) settings. IP testing strains trial subjects, investigators, and budgets. Outpatient (OP) testing may be a solution although there are few reports on OP BCF testing variability. We compared variability metrics between OP and IP from a standardized mixed meal tolerance test (MMTT) and arginine stimulation test (AST) in two separate type 2 diabetes (T2DM) cohorts (OP, n = 20; IP n = 22) in test-retest de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…For MMT, several reports were found in the clinical study for breakfast. One is a standardized mixed meal tolerance test (MMTT) for assessment of the ability of beta cell of the pancreas [32].…”
Section: Discussionmentioning
confidence: 99%
“…For MMT, several reports were found in the clinical study for breakfast. One is a standardized mixed meal tolerance test (MMTT) for assessment of the ability of beta cell of the pancreas [32].…”
Section: Discussionmentioning
confidence: 99%